6505--Levetiracetam Tablets 36E79726R0001

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0001 for an unrestricted procurement for Levetiracetam Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. All unit of use packaging identified in the Schedule of Supplies, (i.e., 60s, 120s) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79726R0001 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about November 10, 2025, with a tentative closing date of November 24, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Youlanda Duggar. Questions can be e-mailed to Youlanda.Duggar@va.gov. The estimated annual requirements are as follows: Line Item 1 Levetiracetam 250mg Tablet, 120 Tablets per Bottle (Unit of Use) Total EST Annual Usage (BT): 9,569 Line Item 2 Levetiracetam 250mg Tablet, 500 Tablets per Bottle Total EST Annual Usage (BT): 4,465 Line Item 3 Levetiracetam 500mg Tablet, 120 Tablets per Bottle (Unit of Use) Total EST Annual Usage (BT): 73,446 Line Item 4 Levetiracetam 500mg Tablet, 500 Tablets per Bottle Total EST Annual Usage (BT): 39,129 Line Item 5 Levetiracetam 750mg Tablet, 120 Tablets per Bottle (Unit of Use) Total EST Annual Usage (BT): 47,472 Line Item 6 Levetiracetam 750mg Tablet, 500 Tablets per Bottle Total EST Annual Usage (BT): 15,750 Line Item 7 Levetiracetam 1,000mg Tablet, 60 Tablets per Bottle (Unit of Use) Total EST Annual Usage (BT): 97,277

Page 2 of 2 Amendment to Extend Due Date and Time for Offers This amendment is issued to extend the due date and time for receipt of offers submitted in response to solicitation 36E79726R0001 for Levetiracetam Tablets from 11/26/2025 to 12/03/2026 at 2:30PM Central Time. All other solicitation terms and conditions remain unchanged. Offerors shall include a completed and signed copy of the amendment with their proposal.